TY - JOUR AU - Abel, S. AU - Hasan, S. AU - Horne, Z. D. AU - Colonias, A. AU - Wegner, R. E. PY - 2019 DA - 2019// TI - Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications JO - Lung Cancer Manag VL - 8 UR - https://doi.org/10.2217/lmt-2018-0013 DO - 10.2217/lmt-2018-0013 ID - Abel2019 ER - TY - JOUR AU - Timmerman, R. AU - Paulus, R. AU - Galvin, J. PY - 2010 DA - 2010// TI - Stereotactic body radiation therapy for inoperable early stage lung cancer JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.261 DO - 10.1001/jama.2010.261 ID - Timmerman2010 ER - TY - JOUR AU - Videtic, G. M. M. AU - Donington, J. AU - Giuliani, M. PY - 2017 DA - 2017// TI - Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline JO - Pract Radiat Oncol VL - 7 UR - https://doi.org/10.1016/j.prro.2017.04.014 DO - 10.1016/j.prro.2017.04.014 ID - Videtic2017 ER - TY - JOUR AU - Palma, D. A. AU - Olson, R. AU - Harrow, S. PY - 2019 DA - 2019// TI - Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)32487-5 DO - 10.1016/S0140-6736(18)32487-5 ID - Palma2019 ER - TY - JOUR AU - Helou, J. AU - Thibault, I. AU - Poon, I. PY - 2017 DA - 2017// TI - Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter JO - Int J Radiat Oncol Biol Phys VL - 98 UR - https://doi.org/10.1016/j.ijrobp.2017.02.093 DO - 10.1016/j.ijrobp.2017.02.093 ID - Helou2017 ER - TY - JOUR AU - Cheung, P. PY - 2016 DA - 2016// TI - Stereotactic body radiotherapy for oligoprogressive cancer JO - Br J Radiol VL - 89 UR - https://doi.org/10.1259/bjr.20160251 DO - 10.1259/bjr.20160251 ID - Cheung2016 ER - TY - JOUR AU - Rose, F. AU - Cozzi, L. AU - Navarria, P. PY - 2016 DA - 2016// TI - Clinical outcome of stereotactic ablative body radiotherapy for lung metastatic lesions in non-small cell lung Cancer Oligometastatic patients JO - Clin Oncol (R Coll Radiol) VL - 28 UR - https://doi.org/10.1016/j.clon.2015.08.011 DO - 10.1016/j.clon.2015.08.011 ID - Rose2016 ER - TY - JOUR AU - Timmerman, R. AU - McGarry, R. AU - Yiannoutsos, C. PY - 2006 DA - 2006// TI - Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.07.5937 DO - 10.1200/JCO.2006.07.5937 ID - Timmerman2006 ER - TY - JOUR AU - Chaudhuri, A. A. AU - Tang, C. AU - Binkley, M. S. PY - 2015 DA - 2015// TI - Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors JO - Lung Cancer VL - 89 UR - https://doi.org/10.1016/j.lungcan.2015.04.014 DO - 10.1016/j.lungcan.2015.04.014 ID - Chaudhuri2015 ER - TY - JOUR AU - Lischalk, J. W. AU - Malik, R. M. AU - Collins, S. P. AU - Collins, B. T. AU - Matus, I. A. AU - Anderson, E. D. PY - 2016 DA - 2016// TI - Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0608-8 DO - 10.1186/s13014-016-0608-8 ID - Lischalk2016 ER - TY - JOUR AU - Haasbeek, C. J. A. AU - Lagerwaard, F. J. AU - Slotman, B. J. AU - Senan, S. PY - 2011 DA - 2011// TI - Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer JO - J Thorac Oncol VL - 6 UR - https://doi.org/10.1097/JTO.0b013e31822e71d8 DO - 10.1097/JTO.0b013e31822e71d8 ID - Haasbeek2011 ER - TY - JOUR AU - Roesch, J. AU - Panje, C. AU - Sterzing, F. PY - 2016 DA - 2016// TI - SBRT for centrally localized NSCLC - what is too central? JO - Radiat Oncol VL - 11 UR - https://doi.org/10.1186/s13014-016-0732-5 DO - 10.1186/s13014-016-0732-5 ID - Roesch2016 ER - TY - STD TI - Bezjak A, Paulus R, Gaspar LE, et al. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG oncology/RTOG 0813 Trial. JCO. 2019:JCO.18.00622. https://doi.org/10.1200/JCO.18.00622. ID - ref13 ER - TY - JOUR AU - Giuliani, M. AU - Mathew, A. S. AU - Bahig, H. PY - 2018 DA - 2018// TI - SUNSET: stereotactic radiation for Ultracentral non-small-cell lung Cancer-a safety and efficacy trial JO - Clin Lung Can VL - 19 UR - https://doi.org/10.1016/j.cllc.2018.04.001 DO - 10.1016/j.cllc.2018.04.001 ID - Giuliani2018 ER - TY - JOUR AU - Taremi, M. AU - Hope, A. AU - Dahele, M. PY - 2012 DA - 2012// TI - Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.12.039 DO - 10.1016/j.ijrobp.2010.12.039 ID - Taremi2012 ER - TY - JOUR AU - Raman, S. AU - Yau, V. AU - Pineda, S. PY - 2018 DA - 2018// TI - Ultracentral tumors treated with stereotactic body radiotherapy: single-institution experience JO - Clin Lung Can VL - 19 UR - https://doi.org/10.1016/j.cllc.2018.06.001 DO - 10.1016/j.cllc.2018.06.001 ID - Raman2018 ER - TY - JOUR AU - Onishi, H. AU - Araki, T. AU - Shirato, H. PY - 2004 DA - 2004// TI - Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study JO - Cancer VL - 101 UR - https://doi.org/10.1002/cncr.20539 DO - 10.1002/cncr.20539 ID - Onishi2004 ER - TY - JOUR AU - Senthi, S. AU - Haasbeek, C. J. A. AU - Slotman, B. J. AU - Senan, S. PY - 2013 DA - 2013// TI - Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review JO - Radiother Oncol VL - 106 UR - https://doi.org/10.1016/j.radonc.2013.01.004 DO - 10.1016/j.radonc.2013.01.004 ID - Senthi2013 ER - TY - JOUR AU - Haseltine, J. M. AU - Rimner, A. AU - Gelblum, D. Y. PY - 2016 DA - 2016// TI - Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree JO - Pract Radiat Oncol VL - 6 UR - https://doi.org/10.1016/j.prro.2015.09.012 DO - 10.1016/j.prro.2015.09.012 ID - Haseltine2016 ER - TY - JOUR AU - Tekatli, H. AU - Haasbeek, N. AU - Dahele, M. PY - 2016 DA - 2016// TI - Outcomes of Hypofractionated high-dose radiotherapy in poor-risk patients with “Ultracentral” non-small cell lung Cancer JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2016.03.008 DO - 10.1016/j.jtho.2016.03.008 ID - Tekatli2016 ER - TY - JOUR AU - Senthi, S. AU - Lagerwaard, F. J. AU - Haasbeek, C. J. A. AU - Slotman, B. J. AU - Senan, S. PY - 2012 DA - 2012// TI - Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70242-5 DO - 10.1016/S1470-2045(12)70242-5 ID - Senthi2012 ER - TY - JOUR AU - Dosani, M. AU - Yang, R. AU - McLay, M. PY - 2019 DA - 2019// TI - Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy JO - Curr Oncol VL - 26 UR - https://doi.org/10.3747/co.26.4167 DO - 10.3747/co.26.4167 ID - Dosani2019 ER - TY - JOUR AU - Chang, J. H. AU - Poon, I. AU - Erler, D. AU - Zhang, L. AU - Cheung, P. PY - 2018 DA - 2018// TI - The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors JO - Radiother Oncol VL - 129 UR - https://doi.org/10.1016/j.radonc.2018.07.001 DO - 10.1016/j.radonc.2018.07.001 ID - Chang2018 ER - TY - JOUR AU - Modh, A. AU - Rimner, A. AU - Williams, E. PY - 2014 DA - 2014// TI - Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy JO - Int J Radiat Oncol Biol Phys VL - 90 UR - https://doi.org/10.1016/j.ijrobp.2014.08.008 DO - 10.1016/j.ijrobp.2014.08.008 ID - Modh2014 ER - TY - JOUR AU - Langendijk, J. A. AU - Tjwa, M. K. AU - Jong, J. M. AU - GP, V. AU - Wouters, E. F. PY - 1998 DA - 1998// TI - Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? JO - Radiother Oncol VL - 49 UR - https://doi.org/10.1016/S0167-8140(98)00103-0 DO - 10.1016/S0167-8140(98)00103-0 ID - Langendijk1998 ER - TY - JOUR AU - Stam, B. AU - Kwint, M. AU - Guckenberger, M. PY - 2019 DA - 2019// TI - Subgroup survival analysis in stage I-II NSCLC patients with a central tumor partly treated with risk-adapted SBRT JO - Int J Radiat Oncol Biol Phys VL - 103 UR - https://doi.org/10.1016/j.ijrobp.2018.08.040 DO - 10.1016/j.ijrobp.2018.08.040 ID - Stam2019 ER - TY - JOUR AU - Ueki, N. AU - Matsuo, Y. AU - Togashi, Y. PY - 2015 DA - 2015// TI - Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000359 DO - 10.1097/JTO.0000000000000359 ID - Ueki2015 ER - TY - JOUR AU - Glick, D. AU - Lyen, S. AU - Kandel, S. PY - 2018 DA - 2018// TI - Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival in patients treated with lung stereotactic body radiation therapy (SBRT) JO - Clin Lung Can VL - 19 UR - https://doi.org/10.1016/j.cllc.2017.06.021 DO - 10.1016/j.cllc.2017.06.021 ID - Glick2018 ER - TY - JOUR AU - Murrell, D. H. AU - Laba, J. M. AU - Erickson, A. AU - Millman, B. AU - Palma, D. A. AU - Louie, A. V. PY - 2018 DA - 2018// TI - Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk? JO - Radiat Oncol VL - 13 UR - https://doi.org/10.1186/s13014-018-1001-6 DO - 10.1186/s13014-018-1001-6 ID - Murrell2018 ER - TY - JOUR AU - Benedict, S. H. AU - Yenice, K. M. AU - Followill, D. PY - 2010 DA - 2010// TI - Stereotactic body radiation therapy: the report of AAPM task group 101 JO - Med Phys VL - 37 UR - https://doi.org/10.1118/1.3438081 DO - 10.1118/1.3438081 ID - Benedict2010 ER -